WASHINGTON (AP) — U.S. Supreme Court justices on Tuesday did not appear ready to limit access to the abortion pill mifepristone, in a case that could have far-reaching implications for millions of American women and for scores of drugs regulated by the Food and Drug Administration. It’s the first abortion-related case the court has taken since a majority of the current justices struck down the constitutional right to abortion in 2022. A group of anti-abortion doctors had asked the court to restrict access to mifepristone and to limit when in a pregnancy it could be used. Key moments from the arguments: |
Beijing eases restrictions on homeBiden awards Presidential Medal of Freedom to these 19 peopleDua Lipa's 'Radical Optimism' review: Controlled but catchy dance popWilliams brothers star for Athletic Bilbao in win over GetafeKremlin critics say Russia is targeting its foes abroad with killings, poisonings and harassmentSebastian Munoz shoots 6Israeli PM vows ground attack on Rafah with or without dealAP PHOTOS: Greek Orthodox mark Good Friday with solemn bier processionsFlood and landslide hit Indonesia's Sulawesi island, killing 14Biden awards Presidential Medal of Freedom to these 19 people